Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mirum Pharmaceuticals
Pharma
Mirum's Ctexli scores FDA approval in rare metabolic disorder
The FDA on Friday gave the green light to Mirum’s Ctexli for the treatment of adults with the rare metabolic disorder cerebrotendinous xanthomatosis.
Fraiser Kansteiner
Feb 21, 2025 3:30pm
Mirum gets 2nd indication for blockbuster hopeful Livmarli
Mar 13, 2024 6:20pm
Travere cuts 20% of workforce, aims to win full nod for Filspari
Dec 5, 2023 11:26am
Mirum ponies up $445M for 2 Travere liver disease drugs
Jul 18, 2023 8:00am
Ipsen pays $952M to acquire Albireo and liver disease med Bylvay
Jan 9, 2023 10:05am
Mirum gets a leg up on Albireo in pediatric liver disease
Oct 24, 2022 3:11pm
